Zobrazeno 1 - 10
of 5 386
pro vyhledávání: '"Ware JA"'
Autor:
Beza-Beza CF; Department of Entomology, University of Minnesota, St Paul, Minnesota, USA.; Department of Entomology and Plant Pathology, North Carolina State University, Raleigh, North Carolina, USA., Wiegmann BM; Department of Entomology and Plant Pathology, North Carolina State University, Raleigh, North Carolina, USA., Ware JA; Department of Biological Sciences, Rutgers University, Newark, New Jersey, USA., Petersen M; Department of Entomology, University of Minnesota, St Paul, Minnesota, USA., Gunter N; Biodiversity and Geosciences Program, Queensland Museum, South Brisbane, Queensland, Australia., Cole ME; Department of Entomology and Plant Pathology, North Carolina State University, Raleigh, North Carolina, USA., Schwarz M; Department of Entomology and Plant Pathology, North Carolina State University, Raleigh, North Carolina, USA., Bertone MA; Department of Entomology and Plant Pathology, North Carolina State University, Raleigh, North Carolina, USA., Young D; Department of Entomology, University of Wisconsin, Madison, Wisconsin, USA., Mikaelyan A; Department of Entomology and Plant Pathology, North Carolina State University, Raleigh, North Carolina, USA.
Publikováno v:
BioEssays : news and reviews in molecular, cellular and developmental biology [Bioessays] 2024 May; Vol. 46 (5), pp. e2300241. Date of Electronic Publication: 2024 Mar 27.
Periodical
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sharma S; AstraZeneca, South San Francisco, California, USA., Pepin X; New Modalities and Parenteral Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, England, UK., Burri H; AstraZeneca, South San Francisco, California, USA., Zheng L; AstraZeneca, South San Francisco, California, USA., Kuptsova-Clarkson N; AstraZeneca, Gaithersburg, Maryland, USA., de Jong A; Acerta Pharma B.V., Oss, The Netherlands., Yu T; AstraZeneca, South San Francisco, California, USA., MacArthur HL; AstraZeneca, Mississauga, Ontario, Canada., Majewski M; AstraZeneca, Mississauga, Ontario, Canada., Byrd JC; Department of Internal Medicine and University of Cincinnati Cancer Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Furman RR; New York-Presbyterian/Weill Cornell Medicine, New York, New York, USA., Ware JA; AstraZeneca, South San Francisco, California, USA., Mann J; Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, England, UK., Ramies D; AstraZeneca, South San Francisco, California, USA., Munugalavadla V; AstraZeneca, South San Francisco, California, USA., Sheridan L; Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, England, UK., Tomkinson H; AstraZeneca, Cambridge, England, UK.
Publikováno v:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2022 Nov; Vol. 11 (11), pp. 1294-1307. Date of Electronic Publication: 2022 Aug 27.
Autor:
Sharma S; Quantitative Clinical Pharmacology, AstraZeneca, South San Francisco, CA, USA., Pepin X; New Modalities & Parenteral Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, UK., Cheung J; Hematology, Research and Development, AstraZeneca, South San Francisco, CA, USA., Zheng L; Late Hematology Statistics, Oncology Biometrics, AstraZeneca, South San Francisco, CA, USA., Wei H; Acerta Pharma (a member of the AstraZeneca Group), South San Francisco, CA, USA., Townsley D; Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA., Han D; Parexel International Early Phase Clinical Unit (Los Angeles), Glendale, CA, USA., Majewski M; Oncology Research and Development, Clinical Operations, AstraZeneca, Toronto, Canada., Ware JA; Acerta Pharma (a member of the AstraZeneca Group), South San Francisco, CA, USA., Mann J; Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, UK., Munugalavadla V; Translational Medicine, Hematology, Research and Early Development, AstraZeneca, South San Francisco, CA, USA., Sheridan L; Product Leadership, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, UK., Patel P; Clinical Development Hematology, Oncology Research and Development, AstraZeneca, South San Francisco, CA, USA., Gupta A; Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA., Tomkinson H; Clinical Pharmacology & Quantitative Pharmacology (CPQP), Clinical Pharmacology and Safety Sciences, Research and Development, AstraZeneca, Cambridge, UK.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2022 Oct; Vol. 88 (10), pp. 4573-4584. Date of Electronic Publication: 2022 May 25.
Autor:
Xu Y; Quantitative Clinical Pharmacology, AstraZeneca, South San Francisco, California, USA., Izumi R; Clinical Development, AstraZeneca, South San Francisco, California, USA., Nguyen H; Clinical Development, AstraZeneca, South San Francisco, California, USA., Kwan A; Clinical Development, AstraZeneca, South San Francisco, California, USA., Kuo H; Quantitative Clinical Pharmacology, AstraZeneca, South San Francisco, California, USA., Madere J; Clinical Development, AstraZeneca, South San Francisco, California, USA., Slatter JG; Quantitative Clinical Pharmacology, AstraZeneca, South San Francisco, California, USA., Podoll T; Quantitative Clinical Pharmacology, AstraZeneca, South San Francisco, California, USA., Vishwanathan K; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, AstraZeneca, Boston, Massachusetts, USA., Marbury T; Orlando Clinical Research Center, Orlando, Florida, USA., Smith W; Alliance for Multispecialty Research, University of Tennessee Medical Center, Knoxville, Tennessee, USA., Preston RA; Division of Clinical Pharmacology, Department of Medicine, The Peggy and Harold Katz Family Drug Discovery Center, University of Miami Clinical and Translational Science Institutes (CTSI), University of Miami, Miami, Florida, USA., Sharma S; Quantitative Clinical Pharmacology, AstraZeneca, South San Francisco, California, USA., Ware JA; Quantitative Clinical Pharmacology, AstraZeneca, South San Francisco, California, USA.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2022 Jun; Vol. 62 (6), pp. 812-822. Date of Electronic Publication: 2022 Feb 15.
Autor:
Gadkar K; Genentech, South San Francisco, California, USA., Friedrich C; Rosa & Co., LLC, San Carlos, California, USA., Hurez V; Rosa & Co., LLC, San Carlos, California, USA., Ruiz ML; Rosa & Co., LLC, San Carlos, California, USA., Dickmann L; Genentech, South San Francisco, California, USA., Kumar Jolly M; Genentech, South San Francisco, California, USA., Schutt L; Genentech, South San Francisco, California, USA., Jin J; Genentech, South San Francisco, California, USA., Ware JA; Genentech, South San Francisco, California, USA., Ramanujan S; Genentech, South San Francisco, California, USA.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2022 May; Vol. 11 (5), pp. 616-627. Date of Electronic Publication: 2021 Dec 13.
Publikováno v:
Morrissey, KM; Benet, LZ; & Ware, JA. (2017). Commentary on: "Influence of OATP1B1 Function on the Disposition of Sorafenib-beta-D-Glucuronide". CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 10(4), 240-241. doi: 10.1111/cts.12476. UCSF: Retrieved from: http://www.escholarship.org/uc/item/0qx7b8n1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::f596e18210e4ef1bc4ea424801721257
http://www.escholarship.org/uc/item/0qx7b8n1
http://www.escholarship.org/uc/item/0qx7b8n1
Publikováno v:
Clinical and translational science, vol 10, iss 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::c860a3db3d6749ad63cfd185c25bda2f
https://escholarship.org/uc/item/0qx7b8n1
https://escholarship.org/uc/item/0qx7b8n1
Autor:
Pilla Reddy V; Early Oncology, Oncology Research & Development, AstraZeneca, Cambridge, UK. Venkatesh.Reddy@astrazeneca.com.; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, Biopharmaceuticals Research & Development, AstraZeneca, Cambridge, UK. Venkatesh.Reddy@astrazeneca.com., Fretland AJ; Early Oncology, Oncology Research & Development, AstraZeneca, Boston, MA, USA., Zhou D; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, Biopharmaceuticals Research & Development, AstraZeneca, Boston, MA, USA., Sharma S; Quantitative Clinical Pharmacology, AstraZeneca , South San Francisco, CA, USA., Chen B; Quantitative Clinical Pharmacology, AstraZeneca , South San Francisco, CA, USA., Vishwanathan K; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, Biopharmaceuticals Research & Development, AstraZeneca, Boston, MA, USA., McGinnity DF; Early Oncology, Oncology Research & Development, AstraZeneca, Cambridge, UK., Xu Y; Quantitative Clinical Pharmacology, AstraZeneca , South San Francisco, CA, USA., Ware JA; Quantitative Clinical Pharmacology, AstraZeneca , South San Francisco, CA, USA.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2021 Sep; Vol. 88 (3), pp. 451-464. Date of Electronic Publication: 2021 Jun 02.
Autor:
Yue Q; Drug Metabolism and Pharmacokinetics, Genentech Inc, South San Francisco, CA, USA., Khojasteh SC; Drug Metabolism and Pharmacokinetics, Genentech Inc, South San Francisco, CA, USA., Cho S; Drug Metabolism and Pharmacokinetics, Genentech Inc, South San Francisco, CA, USA., Ma S; Drug Metabolism and Pharmacokinetics, Genentech Inc, South San Francisco, CA, USA., Mulder T; Drug Metabolism and Pharmacokinetics, Genentech Inc, South San Francisco, CA, USA., Chen J; Drug Metabolism and Pharmacokinetics, Genentech Inc, South San Francisco, CA, USA., Pang J; Drug Metabolism and Pharmacokinetics, Genentech Inc, South San Francisco, CA, USA., Ding X; Drug Metabolism and Pharmacokinetics, Genentech Inc, South San Francisco, CA, USA., Deese A; Small Molecule Pharmaceutical Sciences, Genentech Inc, South San Francisco, CA, USA., Pellet JD; Small Molecule Pharmaceutical Sciences, Genentech Inc, South San Francisco, CA, USA., Siebers N; Covance Clinical Research Unit, 3402 Kinsman Boulevard, Madison, WI, USA., Joas L; Covance Clinical Research Unit, 3402 Kinsman Boulevard, Madison, WI, USA., Salphati L; Drug Metabolism and Pharmacokinetics, Genentech Inc, South San Francisco, CA, USA., Ware JA; Clinical Pharmacology, Genentech Inc, South San Francisco, CA, USA.
Publikováno v:
Xenobiotica; the fate of foreign compounds in biological systems [Xenobiotica] 2021 Jul; Vol. 51 (7), pp. 796-810. Date of Electronic Publication: 2021 May 24.